Techno Medica Co.,Ltd. [6678.T]
TOKYO, Jun 02 (Pulse News Wire) – Techno Medica CO.,LTD. (6678.T) announced today that its board of directors has decided to discontinue its shareholder benefits program due to rising costs and unstable supply conditions.
The company believes that enhancing dividend payouts provides a more stable and equitable return to shareholders. Effective September 30, 2026, the benefits program will cease, focusing instead on increasing dividends. In a related development, Techno Medica previously disclosed plans to boost dividend payout ratios to over 80% percent during the fiscal period ending March 2028.
Originally set at ¥68 per share, the dividend amount has now been increased to ¥129 per share. This adjustment reflects the company's commitment to strengthening shareholder returns through consistent dividend growth. Techno Medica emphasizes that this decision aligns with its goal of maintaining high investor satisfaction while adapting to changing economic environments.
The company requests understanding from its shareholders and looks forward to continued support.
🟢 Confidence: High AI-translated content.